Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents

7Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Atopic dermatitis (AD) is a chronic inflammatory disease with a heterogeneous pathogenesis correlated with dysregulation of the immune system and a prevalence of the T2-mediated immune pathway. Recent understanding of the pathogenesis of AD has allowed the development of new drugs targeting different mechanisms and cytokines that have changed the treatment approach. The aim of this review is to update knowledge on the standard of care and recent advancements in the control of skin inflammation. In light of recent guidelines, we report on the clinical efficacy of novel treatments, with special attention to situations where biologics and small molecules are involved.

Cite

CITATION STYLE

APA

Caffarelli, C., Giannetti, A., Giannì, G., & Ricci, G. (2023). Anti-inflammatory and biologic drugs for atopic dermatitis: a therapeutic approach in children and adolescents. Frontiers in Medicine. Frontiers Media SA. https://doi.org/10.3389/fmed.2023.1214963

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free